Results 281 to 290 of about 178,854 (310)

Reverse Transcriptase Inhibitors

2015
openaire   +1 more source

Nucleoside reverse transcriptase inhibitors

Reactions Weekly, 2003
openaire   +1 more source

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

Reverse transcriptase inhibitors

2011
openaire   +1 more source

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

Reverse transcriptase inhibitors

2006
openaire   +1 more source

Protease inhibitors/nucleoside reverse transcriptase inhibitors

Reactions Weekly, 2020
openaire   +1 more source

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

HIV Nucleoside Reverse Transcriptase Inhibitors

2007
openaire   +1 more source

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly